Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors

J.C. Soria, F.A. Shepherd, JY Douillard, J. Wolf, G. Giaccone, L. Crino, F. Cappuzzo, S. Sharma, S.H. Gross, S. Dimitrijevic, L. Di Scala, H. Gardner, L. Nogova, V. Papadimitrakopoulou

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1674-1681
JournalAnnals of Oncology
Volume20
Issue number10
DOIs
Publication statusPublished - 2009

Cite this

Soria, J. C., Shepherd, F. A., Douillard, JY., Wolf, J., Giaccone, G., Crino, L., ... Papadimitrakopoulou, V. (2009). Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Annals of Oncology, 20(10), 1674-1681. https://doi.org/10.1093/annonc/mdp060